Emergency Medicine

HIV / AIDS

Medical News

Primary Care

Surgery

Home » Medical Industry, diabetes

Interferon Alpha Can Delay Full Onset Of Type I Diabetes, Phase II Trial Suggests

Submitted by MedicalReplies on Wednesday, 1 July 2009No Comment

A low dose of oral interferon alpha shows promise in preserving beta cell function for patients with newly diagnosed type 1 diabetes, or juvenile diabetes, according to the results of a Phase II trial.

See the original post: 
Interferon Alpha Can Delay Full Onset Of Type I Diabetes, Phase II Trial Suggests

Popularity: 3%

You may also like:

Leave your response!

Add your comment below, or trackback from your own site. You can also subscribe to these comments via RSS.

Be nice. Keep it clean. Stay on topic. No spam.

You can use these tags:
<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

This is a Gravatar-enabled weblog. To get your own globally-recognized-avatar, please register at Gravatar.

*
To prove you're a person (not a spam script), type the security word shown in the picture.
Anti-spam image